Jul 15, 2025 | Alternative Reimbursement Strategies, Client Report, MedBen Analytics, MedBen Rx, MedBen WellLiving, Proven solutions, Research, Survey
According to a recent national survey of over 1,800 U.S. employers, reducing health care costs has surpassed attracting and retaining talent as the top driver of benefits decision-making – a first since the survey began in 2019. Additionally, 53% of employers say they...
Jul 14, 2025 | Announcements, Compliance, Consumer-driven Health Plans, Dependent care assistance plan (DCAP), Flexible spending accounts (FSAs), Legislative, Regulatory
The recently enacted “One Big Beautiful Bill” Act (H.R. 1) includes a long-awaited update for working families: a permanent increase in the annual contribution limit for dependent care assistance flexible spending accounts (DCAPs). Beginning in tax years after...
Jul 11, 2025 | Comparative Effectiveness, Cost Savings, Drug advertising, Drug costs, Health care costs, High-value formulary, MedBen Rx, Pharmacy, Rx Costs, Spending
Pharmaceutical advertising hit a record high in 2024, with the top 10 drugs accounting for $3.3 billion in ad spending – up nearly 20% from the previous year. With more campaigns directly targeting consumers, MedBen Rx’s high-value formulary educates members about...
Jul 10, 2025 | Cost Savings, Health care costs, Trend
Per Fierce Healthcare: “A new report from federal actuaries estimates national health spending will increase by 7.1% in 2025, with spending growth set to outpace growth in the U.S. gross domestic product.” Historically, MedBen clients have maintained a cost trend...
Jul 1, 2025 | Cost Savings, Drug costs, GLP-1s, MedBen Rx, Ozempic, Rebates, Rx Costs, Specialty Drugs, Wegovy, Weight loss drugs
The 2025 Milliman Medical Index confirms what many employers are seeing firsthand: prescription drug costs are rising faster than any other health care expense, with a 9.7% increase over the past year. To help employers reclaim their drug spend, MedBen Rx offers a...
